Human Genome Sciences, GlaxoSmithKline deal

HGSI received a $7 million milestone from GSK under a 2004 deal to develop and commercialize GSK716155 to treat diabetes (see BioCentury, Nov. 1, 2004). The payment was triggered by the achievement o...